CDC advisers vote to narrow the use of J&J vaccine due to concerns about rare blood clots

The recommendation was prompted by the occurrence of a rare and sometimes fatal blood clotting problem known as TTS. More than 16 million people in the U.S. have received a shot of the Johnson & Johnson vaccine.

CDC advisers vote to narrow the use of J&J vaccine due to concerns about rare blood clots The recommendation was prompted by the occurrence of a rare and sometimes fatal blood clotting problem known as TTS. More than 16 million people in the U.S. have received a shot of the Johnson & Johnson vaccine. Read More You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy